Menu
Sign In Pricing Add Podcast

Acquired

Novo Nordisk (Ozempic)

141.454 - 158.343 David Rosenthal

Yeah, it's wild. I mean, there are no other disease and drug categories besides diabetes and obesity that this could be possible to have a company of this size to have a pharma giant pretty much just focused on this one area. Like this is the Hermes of the pharma industry.

0
💬 0

Comments

There are no comments yet.

Log in to comment.